Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Jul 23, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2018 PForm 4 → | Jul 20, 4:40 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Growth Equity Opportunities IV, LLC +310% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:41 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Peter J Barris10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:41 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Forest Baskett10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:42 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Anthony A. Florence Jr.10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:43 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Mohamad Makhzoumi10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:43 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Joshua Makower10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:44 pm EDT | AVEO PHARMACEUTICALS INCAVEO | David M Mott10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:44 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Scott D Sandell10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:45 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Peter W. Sonsini10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 4:45 pm EDT | AVEO PHARMACEUTICALS INCAVEO | Ravi Viswanathan10% Owner | 250,600 | $1.96 | $491,745 | 18,034,322 | +1.41% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 10:49 am EDT | HEMISPHERX BIOPHARMA INCHEB | Thomas K. EquelsExec. Vice Chairman/CEO/Pres., Director | 112,904 | $0.31 | $35,000 | 637,823 | +21.5% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 9:32 am EDT | HEMISPHERX BIOPHARMA INCHEB | Adam PascaleCFO | 32,259 | $0.31 | $10,000 | 59,648 | +118% | plan? |
| Jul 23, 2018 PForm 4 → | Jul 23, 10:06 am EDT | HEMISPHERX BIOPHARMA INCHEB | Wayne S SpringateSr. VP of Operations | 32,259 | $0.31 | $10,000 | 64,773 | +99.2% | plan? |
| Jul 18, 2018 PForm 4 → | Jul 20, 5:00 pm EDT | Jaguar Health, Inc.JAGX | Jonathan B. SiegelDirector | 5,000 | $1.10 | $5,476 | 14,732 | +51.4% | plan? |
| Jul 20, 2018 PForm 4 → | Jul 23, 1:03 pm EDT | CGE ENERGY, INC.CGEI | CGE ENERGY, INC.PRESIDENT / CEO, Director, 10% Owner | 5,000 | $0.265 | $1,325 | 24,734,135 | +0.02% | plan? |
| Jul 17, 2018 PForm 4 → | Jul 20, 8:12 pm EDT | IGEN NETWORKS CORPIGEN | Abel Israel Sierra Sr.VP/GM | 20,000 | $0.04 | $800 | 170,000 | +13.3% | plan? late |
| Jul 16, 2018 PForm 4 → | Jul 20, 4:12 pm EDT | ENDONOVO THERAPEUTICS, INC.ENDV | Michael Scott MannPresident, 10% Owner | 18,009 | $0.0348 | $628 | 25,200,298 | +0.07% | plan? late |
| Jul 23, 2018 PForm 4 → | Jul 23, 3:27 pm EDT | Luvu Brands, Inc.LUVU | Ronald P ScottCFO, Director | 10,000 | $0.0443 | $443 | 270,516 | +3.84% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.